D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Applied Digital
APLD
$6.68B
| $8M | 0.01% |
+1,046,595
| New | +$8.7M |
|
1527
Global E Online
GLBE
$6.76B
| $7.99M | 0.01% |
+146,468
| New | +$6.63M |
|
1528
Aptiv
APTV
$12.3B
| $7.93M | 0.01% |
131,140
-180,922
| -58% | -$11.1M |
|
1529
CALL
Gilead Sciences
GILD
$165B
| $7.93M | 0.01% |
85,800
-34,800
| -29% | -$3.13M |
|
|
HPP
1530
Hudson Pacific Properties
HPP
$758M
| $7.89M | 0.01% |
372,217
+182,177
| +96% | +$4.98M |
|
1531
CALL
Bunge Global
BG
$20.9B
| $7.89M | 0.01% |
101,500
+29,300
| +41% | +$2.57M |
|
1532
Gartner
IT
$11.1B
| $7.87M | 0.01% |
16,254
-43,584
| -73% | -$22.5M |
|
|
AVNS
1533
DELISTED
Avanos Medical
AVNS
| $7.87M | 0.01% |
494,627
+148,902
| +43% | +$2.95M |
|
1534
Theravance Biopharma
TBPH
$873M
| $7.85M | 0.01% |
833,943
+69,178
| +9% | +$629K |
|
1535
Vanguard Health Care ETF
VHT
$18.5B
| $7.84M | 0.01% |
30,917
+26,402
| +585% | +$7.11M |
|
|
EHAB
1536
DELISTED
Enhabit
EHAB
| $7.84M | 0.01% |
1,004,215
+250,215
| +33% | +$1.9M |
|
1537
PUT
Magna International
MGA
$18.8B
| $7.84M | 0.01% |
187,600
+56,600
| +43% | +$2.43M |
|
1538
Harley-Davidson
HOG
$2.61B
| $7.81M | 0.01% |
259,373
-35,866
| -12% | -$1.19M |
|
|
ACCD
1539
DELISTED
Accolade Inc
ACCD
| $7.8M | 0.01% |
2,280,783
+998,423
| +78% | +$3.55M |
|
1540
Solventum
SOLV
$15.3B
| $7.79M | 0.01% |
117,985
+75,171
| +176% | +$5.26M |
|
1541
Xperi
XPER
$364M
| $7.79M | 0.01% |
758,210
+125,021
| +20% | +$1.17M |
|
1542
JELD-WEN Holding
JELD
$110M
| $7.78M | 0.01% |
950,217
+426,085
| +81% | +$5.13M |
|
1543
Gentherm
THRM
$1.32B
| $7.77M | 0.01% |
194,584
+81,780
| +72% | +$3.43M |
|
1544
CALL
Applied Optoelectronics
AAOI
$6.14B
| $7.77M | 0.01% |
+210,700
| New | +$5.67M |
|
1545
US Physical Therapy
USPH
$1.22B
| $7.73M | 0.01% |
87,184
+27,028
| +45% | +$2.41M |
|
|
GATO
1546
DELISTED
Gatos Silver, Inc.
GATO
| $7.72M | 0.01% |
552,479
+257,497
| +87% | +$4.19M |
|
1547
Hyliion Holdings
HYLN
$578M
| $7.7M | 0.01% |
2,949,691
-511,755
| -15% | -$1.42M |
|
1548
SITE Centers
SITC
$236M
| $7.68M | 0.01% |
502,422
-190,318
| -27% | -$3.07M |
|
1549
E.W. Scripps
SSP
$270M
| $7.65M | 0.01% |
3,459,777
-34,172
| -1% | -$78.9K |
|
1550
CALL
XPeng
XPEV
$12.5B
| $7.63M | 0.01% |
645,200
+555,500
| +619% | +$6.87M |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.